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Abstract 
Airway epithelial cells modulate the inflammatory esponse in asthmatic, allergic and fibrotic lung diseases through the 
secretion of cytokines that regulate the movement and activation of inflammatory cells. Mast cells play an important role in 
the pathogenesis of these lung diseases. In this study we report hat normal airway epithelial cells express tem cell factor 
which is a critical mediator of mast cell growth and differentiation and that transforming growth factor-/3 inhibits secretion 
of stem cell factor by airway epithelial cells. 
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Airway epithelial cells participate in regulation of 
the inflammatory response by synthesizing and se- 
creting various cytokines that can act in a paracrine 
manner with infiltrating inflammatory cells [1]. Fur- 
thermore, airway epithelial cells are targets for many 
cytokines produced by inflammatory cells which reg- 
ulate the expression of immune and inflammatory 
airway epithelial cell products. Interactions between 
airway epithelial-derived cytokines and infiltrating 
inflammatory cells regulate local inflammatory and 
immune responses, which are important for host de- 
fense and the pathogenesis of inflammatory airway 
diseases uch as asthma, chronic bronchitis, oblitera- 
tive bronchiolitis, and cystic fibrosis. 
Mast cells are IgE receptor-expressing, effector 
cells of the immune system that play a pivotal role in 
allergic and asthmatic :reactions [2]. In normal air- 
ways there are a small number of mast cells residing 
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in the bronchial submucosa. In allergic and asthmatic 
airways mast cells proliferate and migrate from the 
submucosa into the airway mucosa residing adjacent 
to airway epithelium and activation of mast cells via 
the IgE receptor [3-5] as histamine and neutral pro- 
teases such as tryptase and chymase [6,7] Recent 
studies also suggest a role for mast cells in fibrotic 
lung diseases uch as scleroderma, sarcoidosis and 
idiopathic pulmonary fibrosis [8-10]. 
The process of mast cell proliferation and matura- 
tion appears to be dependent upon the actions of both 
interleukin-3 (IL-3) and the c-kit ligand, stem cell 
factor (SCF). IL-3 appears to be important for early 
mast cell proliferation, whereas SCF acts to maintain 
mast cell viability and promotes mast cell chemotaxis 
and maturation. SCF can be expressed either as a 
soluble or membrane-bound form generated by tis- 
sue-specific splicing [11]. SCF is produced by en- 
dothelial cells, keratinocytes, and stromal cells [12]. 
It promotes an IgE-dependent activation of tissue 
mast cells via the c-kit receptor esulting in local 
release of histamine, neutral proteases, interleukin-5, 
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tumor necrosis factor-a (TNF-ce), and prostaglandin 
D 2 [5]. It is also proposed that low levels of stem cell 
factor in tissue may act as a physiologic stimulus for 
mast cells, leading to baseline synthesis/release of 
mediators [13]. 
Recognizing that mast cells are potentially promi- 
nent mediators of the allergic, asthmatic and fibrotic 
response we speculated that airway epithelial cells 
may produce mediators that promote mast cell growth, 
migration and differentiation. In this study, we show 
that normal airway epithelial cells constitutively ex- 
press SCF, and that TGF-/3 potently inhibits SCF 
secretion by airway epithelial cells. 
Normal human bronchial epithelial cells (NHBE) 
obtained from Clonetics Corp. (La Jolla, CA) and the 
BEAS-2B cell line, an SV-40-transformed airway 
epithelial cell line, obtained from ATCC (Rockville, 
MD) were cultured in serum-free LHC-8e media 
Biofluids (Rockville, MD) as described previously 
[14]. The HT 1080 fibrosarcoma cell line was ob- 
tained from ATCC and maintained in DME media 
with 10% FBS (Gibco BRL, Gaithersburg, MD). 
To determine whether human SCF mRNA was 
produced by NHBE cells we performed reverse tran- 
scription PCR using SCF primers (5' primer: 5'-GAA 
GGG ATC TGC AGG AAT CGT GTG-3'; 3' primer 
5'-TGC AAC AGG GGG TAA CAT AAA TGG- 3'). 
RNA was extracted using a solution that contains 
guanidium isothiocyanate and phenol (RNA-STAT, 
Tel-Test 'B', Friendswood, TX). Following agarose 
gel electrophoresis, we observed a band of 492 bp 
corresponding to the predicted size for SCF (Fig. 1). 
This product was confirmed to be SCF by dideoxy 
sequencing [11]. A band of 492 bp that was also 
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Fig. l. Airway epithelial cells express SCF mRNA. Ethidium 
bromide-stained agarose gel of RT-PCR products from normal 
human bronchial epithelial (NHBE) cells, an SV-40 transformed 
airway epithelial cell line (BEAS-2B), and a fibrosarcoma cell 
line, HT-1080. In the non-DNA lane primers alone were added. 
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Fig. 2. Airway epithelial cells express SCF protein. Cytosolic 
extracts from cell lines described in Fig. 1 that contained equal 
amount of protein were analyzed by SDS-PAGE and then im- 
munoblotted with an anti-human SCF mAb. Molecular weight 
markers are also shown. 
confirmed to be SCF was observed in BEAS-2B cells 
(Fig. 1). SCF mRNA was not expressed in the HT 
1080 fibrosarcoma cell line (Fig. 1). NHBE and 
BEAS-2B cells did not express mRNA for c-kit, the 
receptor for SCF (data not shown). 
We then analyzed whether NHBE cells express 
SCF protein by performing Western blot analysis 
with an anti-SCF monoclonal antibody (Genzyme 
Corp., Cambridge, MA). Cellular proteins were ex- 
tracted with a lysis buffer containing 10 mM Tris-HC1, 
100 mM NaC1, 1% NP-40, 10 /zg/ml aprotonin and 
1 mM sodium orthovanadate. Samples were cen- 
trifuged for 5' to remove insoluble material followed 
by measurement of protein concentration by the 
Bradford method, BioRad Laboratories (Hercules, 
CA). Samples containing equal protein concentrations 
were denatured by boiling and analyzed by SDS- 
PAGE, and then transferred to nitrocellulose. The 
blot was then placed in blocking buffer containing 
1% milk, 1% BSA, 10 mM Tris-HC1 pH 7.5, 100 
mM NaC1, and 0.1% Tween 20 for 1 h at room 
temperature or overnight at 4°C. The blot was then 
incubated in blocking buffer with the anti-SCF anti- 
body at a dilution of 1:500 washed in a solution 
containing 10 mM Tris-HC1, pH 7.5, 100 mM NaC1, 
and 0.1% Tween 20 followed by incubation in block- 
ing buffer containing a horseradish peroxidase conju- 
gated anti-rabbit IgG Caltag Laboratories (San Fran- 
cisco, CA) at a dilution of 1:1500 and detected by 
ECL Amersham (Arlington Heights, IL) followed by 
autoradiography. A band of 32 kDa was observed on 
Western blot, a size that corresponds to one of the 
predicted molecular weights of membrane-bound SCF 
(Fig. 2). SCF can exist as larger 45 kDa and smaller 
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32 kDa forms and both are cleaved to produce solu- 
ble factors. A band of similar size but greater inten- 
sity was observed in BEAS-2B cells (Fig. 2). No 
band was observed in HI' 1080 cells (Fig. 2). 
To determine whether airway epithelial cells pro- 
duce soluble SCF we performed a sandwich enzyme- 
linked immunoabsorbent assay (ELISA) with super- 
natants from NHBE and BEAS-2B cells using the 
protocol provided by the manufacturer (R and D 
Systems, Minneapolis, MN). SCF was detected in the 
supernatant of NHBE cells at levels between 10-20 
pg/ml  (Fig. 3A). SCF was also detected in the 
supernatant of BEAS-2B cells at higher levels be- 
tween 40-50 pg/ml  (Fig. 3A). SCF was not detected 
in the supernatant from media in the absence of cells 
(Fig. 3A). Soluble SCF "was not detected in the HT 
1080 cell line (data not shown). 
To determine if different mediators of lung inflam- 
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Fig. 3. Airway epithelial cells produce soluble SCF. A. Assay of 
SCF in the supernatant of NHBE and BEAS-2B cells by sand- 
wich ELISA. Media refers to LHCSe media without cells. Exper- 
iments were repeated four times with similar esults. B. Effect of 
inflammatory mediators on SCF release. ELISA analysis of SCF 
in the supernatant of NHBE cells following 36 h of treatment 
with TGF-/3 (80 pM), dexarnethasone (1 /~M), TNF-c~ (20 
pg/ml) or histamine (2 mM) Experiments were repeated three 
times with similar esults. 
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Fig. 4. TGF-fl does not affect expression of membrane-bound 
SCF. Cytosolic extracts from unstimulated NHBE cells (control) 
and cells that were treated with TGF-/3 (80 pM) for 24 h 
containing equal amounts of protein were analyzed by SDS-PAGE 
and then immunoblotted with an anti-human SCF mAb. 
mation would affect SCF production by airway ep- 
ithelial cells, we examined the effect of dexametha- 
sone (1 /xM), TNF-a (20 pg/ml), histamine (2 mM) 
and TGF-fl (80 pM) on SCF expression and release 
by airway cells. NHBE cells were treated with these 
mediators for 36 h followed by harvest of the super- 
natants for ELISA. Dexamethasone, histamine and 
tumor necrosis factor-a did not significantly affect 
the amount of SCF detected in the supernatant of 
NHBE cells as detected by ELISA (Fig. 3B) or SCF 
expression on Western blot (data not shown) but 
TGF-fl significantly inhibited production of soluble 
SCF (Fig. 3B). 
Treatment of NHBE cells for 36 h with 80 pM 
TGF-fl caused a 5- to 10-fold reduction in the amount 
of SCF in the supernatant from 10-20 pg/ml  to 1-2 
pg/ml  (Fig. 4). TGF-fl has been shown to induce 
growth arrest and squamous differentiation of NHBE 
cells [15]. Our studies corroborate those findings: 
TGF-/3 decreased 3H-thymidine incorporation by 90% 
at 24 h after the addition of TGF-/3 (data not shown), 
and most cells acquired the spindle shape and elon- 
gated, morphologic haracteristics of squamous dif- 
ferentiation (data not shown). Because TGF-fl in- 
duced growth arrest and differentiation of NHBE 
cells, it was possible that inhibition by TGF-fl of 
soluble SCF release resulted from a decrease in SCF 
protein synthesis. Therefore, we performed a Western 
blot to evaluate SCF protein expression in the pres- 
ence of TGF-/3. Our results show that TGF-/3 did not 
affect the expression of membrane-bound SCF (Fig. 
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4). These data demonstrate that TGF-/3 inhibited 
release of soluble SCF by NHBE cells but did not 
affect expression of membrane-bound SCF. 
In this report we have shown that normal airway 
epithelial cells constitutively express SCF protein and 
soluble SCF in vitro but they do not express c-kit, the 
receptor for SCF. It is possible that airway 
epithelial-derived SCF plays a role in maintaining 
mast cell viability and promoting differentiation and 
chemotaxis of mast cells in normal lung and in 
inflammatory lung diseases. We also observed that 
TGF-fl was a potent inhibitor of SCF secretion by 
NHBE cells. TGF-/3 plays a central role in genera- 
tion of the fibroproliferative r sponse in fibrotic lung 
diseases but its role in asthma is unclear [7,16]. Mast 
cells accumulate at sites of injury during the inflam- 
matory phase of fibrogenic lung injury, but mast cell 
numbers decrease in fibrotic lesions. It is possible 
that inhibition of airway epithelial cell-derived SCF 
by TGF-fl decreases mast cell accumulation and 
survival in more advanced stages of fibrotic lung 
disease. 
The airway epithelium is a dynamic modulator of 
the inflammatory response. Several airway 
epithelial-derived cytokines that affect neutrophils, 
macrophage and lymphocyte accumulation and dif- 
ferentiation have been identified, but this is the first 
example showing that airway epithelial cells produce 
SCF, a factor critical for mast cell function. It will be 
important to examine xpression of SCF by airway 
epithelium in vivo in normal tissue and in asthmatic 
and fibrotic lung tissue in order to corroborate and 
extend our in vitro findings. 
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